109 related articles for article (PubMed ID: 9549830)
1. Detection of minimal residual disease in cerebro-spinal fluid of a patient with acute myelogenous leukemia with t(16;21)(p11;q22) translocation by reverse transcriptase-polymerase chain reaction.
Harigae H; Kobayashi M; Mihara A; Watanabe N
Tohoku J Exp Med; 1997 Dec; 183(4):297-302. PubMed ID: 9549830
[TBL] [Abstract][Full Text] [Related]
2. Detection of minimal residual disease in a patient having acute myelogenous leukemia with t(16;21)(p11;q22) treated by allogeneic bone marrow transplantation.
Okoshi Y; Shimizu S; Kojima H; Obara N; Mukai HY; Komeno T; Hasegawa Y; Mori N; Nagasawa T
Acta Haematol; 2001; 105(1):45-8. PubMed ID: 11340253
[TBL] [Abstract][Full Text] [Related]
3. [Two cases of acute myeloid leukemia with t(16;21)(p11;q22) and TLS/FUS-ERG fusion transcripts].
Chang WR; Park IJ; Lee HW; Park JS; Kim HC; Kim HJ; Han JH; Cho SR
Korean J Lab Med; 2009 Oct; 29(5):390-5. PubMed ID: 19893346
[TBL] [Abstract][Full Text] [Related]
4. Outcome and Minimal Residual Disease Monitoring in Patients with t(16;21) Acute Myelogenous Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.
Qin YZ; Chen Y; Xu LP; Wang Y; Zhang XH; Chen H; Zhao XS; Liu KY; Huang XJ
Biol Blood Marrow Transplant; 2018 Jan; 24(1):163-168. PubMed ID: 28939454
[TBL] [Abstract][Full Text] [Related]
5. Consistent detection of TLS/FUS-ERG chimeric transcripts in acute myeloid leukemia with t(16;21)(p11;q22) and identification of a novel transcript.
Kong XT; Ida K; Ichikawa H; Shimizu K; Ohki M; Maseki N; Kaneko Y; Sako M; Kobayashi Y; Tojou A; Miura I; Kakuda H; Funabiki T; Horibe K; Hamaguchi H; Akiyama Y; Bessho F; Yanagisawa M; Hayashi Y
Blood; 1997 Aug; 90(3):1192-9. PubMed ID: 9242552
[TBL] [Abstract][Full Text] [Related]
6. Competitive CBFbeta/MYH11 reverse-transcriptase polymerase chain reaction for quantitative assessment of minimal residual disease during postremission therapy in acute myeloid leukemia with inversion(16): a pilot study.
Laczika K; Novak M; Hilgarth B; Mitterbauer M; Mitterbauer G; Scheidel-Petrovic A; Scholten C; Thalhammer-Scherrer R; Brugger S; Keil F; Schwarzinger I; Haas OA; Lechner K; Jaeger U
J Clin Oncol; 1998 Apr; 16(4):1519-25. PubMed ID: 9552061
[TBL] [Abstract][Full Text] [Related]
7. Detection of CBFbeta/MYH11 fusion transcripts in patients with inv(16) acute myeloid leukemia after allogeneic bone marrow or peripheral blood progenitor cell transplantation.
Elmaagacli AH; Beelen DW; Kroll M; Trzensky S; Stein C; Schaefer UW
Bone Marrow Transplant; 1998 Jan; 21(2):159-66. PubMed ID: 9489633
[TBL] [Abstract][Full Text] [Related]
8. Establishment and characterization of a novel acute myeloid leukemia cell line, JIH-4, carrying a t(16;21)(p11.2;q22) and expressing the FUS-ERG fusion.
Jiang H; Qiu H; Xue Y; Pan J; Wu Y; Zhang J; Zheng J; Wang Q; Liang J; Chen S
Cancer Genet; 2011 Apr; 204(4):219-23. PubMed ID: 21536242
[TBL] [Abstract][Full Text] [Related]
9. AML1/ETO fusion mRNA can be detected in remission blood samples of all patients with t(8;21) acute myeloid leukemia after chemotherapy or autologous bone marrow transplantation.
Kusec R; Laczika K; Knöbl P; Friedl J; Greinix H; Kahls P; Linkesch W; Schwarzinger I; Mitterbauer G; Purtscher B
Leukemia; 1994 May; 8(5):735-9. PubMed ID: 7514242
[TBL] [Abstract][Full Text] [Related]
10. Unusual type of TLS/FUS-ERG chimeric transcript in a pediatric acute myelocytic leukemia with 47,XX,+10,t(16;21)(p11;q22).
Choi HW; Shin MG; Sawyer JR; Cho D; Kee SJ; Baek HJ; Kook H; Kim HJ; Shin JH; Suh SP; Hwang TJ; Ryang DW
Cancer Genet Cytogenet; 2006 Jun; 167(2):172-6. PubMed ID: 16737920
[TBL] [Abstract][Full Text] [Related]
11. [AML(M7) associated with t(16;21)(p11;q22) showing relapse after unrelated bone marrow transplantation and disappearance of TLS/FUS-ERG mRNA].
Fukushima Y; Fujii N; Tabata Y; Nishimura Y; Fusaoka T; Yoshihara T; Tsunamoto K; Kasubuchi Y; Morimoto A; Hibi S; Taketani K; Hayashi Y; Imashuku S
Rinsho Ketsueki; 2001 Jun; 42(6):502-6. PubMed ID: 11505530
[TBL] [Abstract][Full Text] [Related]
12. TLS/FUS-ERG fusion gene in acute lymphoblastic leukemia with t(16;21)(p11;q22) and monitoring of minimal residual disease.
Kanazawa T; Ogawa C; Taketani T; Taki T; Hayashi Y; Morikawa A
Leuk Lymphoma; 2005 Dec; 46(12):1833-5. PubMed ID: 16263589
[TBL] [Abstract][Full Text] [Related]
13. Quantitative RT-PCR analysis of the MOZ-CBP fusion transcript in therapy-related acute myeloid leukemia with t(8;16)(p11;p13).
Fujiki A; Imamura T; Furutani A; Hatano W; Asai D; Hirashima Y; Miyachi M; Tamura S; Tsuchiya K; Iehara T; Ishida H; Yoshihara T; Hosoi H
J Pediatr Hematol Oncol; 2012 Jul; 34(5):402-5. PubMed ID: 22278196
[TBL] [Abstract][Full Text] [Related]
14. Two childhood cases of acute leukemia with t(16;21)(p11.2;q22): second case report of infantile acute lymphoblastic leukemia with unusual type of FUS-ERG chimeric transcript.
Oh SH; Park TS; Choi JR; Lee S; Cho SY; Kim SY; Kim J; Park JK; Song SA; Lee JY; Shin JH; Kim HR; Lee JN
Cancer Genet Cytogenet; 2010 Jul; 200(2):180-3. PubMed ID: 20620604
[TBL] [Abstract][Full Text] [Related]
15. Minimal residual disease in acute myelogenous leukemia with PML/RAR alpha or AML1/ETO mRNA and phenotypic analysis of possible T and natural killer cells in bone marrow.
Inokuchi K; Iwakiri R; Futaki M; Hanawa H; Tanosaki S; Nomura T; Dan K
Leuk Lymphoma; 1998 May; 29(5-6):553-61. PubMed ID: 9643569
[TBL] [Abstract][Full Text] [Related]
16. Molecular characteristic of acute leukemias with t(16;21)/FUS-ERG.
Zerkalenkova E; Panfyorova A; Kazakova A; Baryshev P; Shelihova L; Kalinina I; Novichkova G; Maschan M; Maschan A; Olshanskaya Y
Ann Hematol; 2018 Jun; 97(6):977-988. PubMed ID: 29427188
[TBL] [Abstract][Full Text] [Related]
17. Fusion of the FUS gene with ERG in acute myeloid leukemia with t(16;21)(p11;q22).
Panagopoulos I; Aman P; Fioretos T; Höglund M; Johansson B; Mandahl N; Heim S; Behrendtz M; Mitelman F
Genes Chromosomes Cancer; 1994 Dec; 11(4):256-62. PubMed ID: 7533529
[TBL] [Abstract][Full Text] [Related]
18. Serial quantification of minimal residual disease of t(8;21) acute myelogenous leukaemia with RT-competitive PCR assay.
Muto A; Mori S; Matsushita H; Awaya N; Ueno H; Takayama N; Okamoto S; Kizaki M; Ikeda Y
Br J Haematol; 1996 Oct; 95(1):85-94. PubMed ID: 8857943
[TBL] [Abstract][Full Text] [Related]
19. Detection of FUS-ERG chimeric transcript in two cases of acute myeloid leukemia with t(16;21)(p11.2;q22) with unusual characteristics.
Kim J; Park TS; Song J; Lee KA; Hong DJ; Min YH; Cheong JW; Choi JR
Cancer Genet Cytogenet; 2009 Oct; 194(2):111-8. PubMed ID: 19781443
[TBL] [Abstract][Full Text] [Related]
20. [Clinical characteristics of acute myeloid leukemia with t (16;21) (p11;q22):nine cases report and literature review].
Ouyang M; Xu LP; Wang Y; Zhu HH; Qin YZ; Lai YY; Liu YR; Jiang B; Huang XJ; Jiang H
Zhonghua Xue Ye Xue Za Zhi; 2016 Mar; 37(3):210-5. PubMed ID: 27033758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
